Cognition Therapeutics Inc (CGTX)
0.7209
+0.07
(+11.25%)
USD |
NASDAQ |
Dec 26, 12:30
Cognition Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| MetaVia Inc | 0.00 |
| Dermata Therapeutics Inc | -- |
| ZyVersa Therapeutics Inc | -- |
| Merck & Co Inc | -3.845B |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.851M |
| Cash from Financing (Quarterly) | 0.329M |
| Free Cash Flow | -25.58M |
| Free Cash Flow Per Share (Quarterly) | -0.1695 |
| Free Cash Flow Yield | -97.72% |